Seligson & Co Global Top 25 Pharmaceuticals Fund A
Do you own Seligson & Co Global Top 25 Pharmaceuticals Fund, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Seligson & Co Global Top 25 Pharmaceuticals Fund and a few more. Free, no card.
Super Stock+59.1%In short
- Seligson & Co Global Top 25 Pharmaceuticals Fund A has risen 19.5% over the past year, including dividends.
- The trend over the past year is better than 71% of funds and ETFs.
- The largest fall over the past three years was 23.5%. The price is 3.6% below its peak now.
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on. Quality and value come from the shares the fund owns. We cannot see this fund's holdings yet, so here are its trend and risk.
- Debt to equityBorrowings divided by equity–
- Asset turnoverSales divided by everything the company owns–
- Return on equityProfit divided by equity–
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
- P/BPrice divided by equity–
- P/SPrice divided by sales–
- P/EPrice divided by earnings–
- P/CFPrice divided by operating cash flow–
The ranking is built on P/E, P/B and P/S.
- 3 months+3.2%
- 6 months+7.0%
- 9 months+6.9%
- 12 months+19.5%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About the fund
Seligson & Co Global Top 25 Pharmaceuticals Fund A is a fund traded in EUR.
See the full analysis in InvestWiser.
The charts, holdings and the comparison with other funds are in the app.
Free forever · No card